Published in Emerg Infect Dis on June 01, 2012
Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence. PLoS One (2014) 0.78
Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis. PLoS One (2016) 0.77
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87
Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol (2007) 5.37
Clostridium difficile--associated diarrhea. Clin Infect Dis (1998) 4.06
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep (2005) 3.60
Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol (2009) 2.00
Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis (2008) 2.00
Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep (2008) 1.98
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol (2010) 1.73
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis (2010) 1.53
Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med (2008) 1.08
Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol (2009) 1.06
Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008. Euro Surveill (2009) 0.79
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother (2006) 4.28
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care (2012) 2.92
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.62
Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol (2007) 2.61
Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf (2012) 2.41
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33
Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf (2004) 2.11
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf (2007) 2.09
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med (2006) 1.91
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ (2005) 1.78
Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am (2013) 1.76
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf (2006) 1.73
Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy (2004) 1.71
Reduction in antibiotic use among US children, 1996-2000. Pediatrics (2003) 1.71
Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med (2006) 1.67
Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis (2012) 1.66
Validity of gout diagnoses in administrative data. Arthritis Rheum (2007) 1.62
AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.57
Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc (2011) 1.57
Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis (2008) 1.54
Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) (2014) 1.54
Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50
Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am Heart J (2004) 1.44
A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3). J Int Assoc Physicians AIDS Care (Chic) (2009) 1.44
Chronic disease score as a predictor of hospitalization. Epidemiology (2002) 1.43
Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. J Am Geriatr Soc (2006) 1.40
Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am (2003) 1.40
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf (2009) 1.38
Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med (2006) 1.37
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther (2009) 1.35
Weight change in diabetes and glycemic and blood pressure control. Diabetes Care (2008) 1.34
Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis (2007) 1.34
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health (2009) 1.34
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics (2004) 1.28
Recent trends in outpatient antibiotic use in children. Pediatrics (2014) 1.26
Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis (2010) 1.24
Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf (2008) 1.21
Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf (2012) 1.20
Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med (2011) 1.14
Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother (2004) 1.12
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12
The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization. Am J Manag Care (2004) 1.12
Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf (2010) 1.12
Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol (2014) 1.11
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med (2008) 1.09
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer (2010) 1.08
Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J (2012) 1.08
Effect of a patient panel-support tool on care delivery. Am J Manag Care (2010) 1.08
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care (2012) 1.05
Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf (2009) 1.03
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03
Use of health information technology to improve medication adherence. Am J Manag Care (2011) 1.03
Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy. Pharmacoepidemiol Drug Saf (2011) 1.02
Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes (2013) 1.01
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) (2006) 1.01
Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis (2006) 1.01
Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain (2012) 0.99